---

Quick Guide to Exam Weightage

• TME technique is the single most exam-important surgical procedure for rectum topics
• Rectal prolapse operations (especially Altemeier and Ventral Mesh Rectopexy) are heavily tested
• The German Rectal Study data for neoadjuvant vs adjuvant CRT is a classic exam fact
• For haemorrhoids: The degree-based treatment ladder should be memorized
• Ischiorectal fossa: Focus on Alcock's canal contents and horseshoe abscess pathway for surgical significance

---

Priority Study Guide for STOMACH

Top 5 Most Repeated/High-Mark Topics

• Memorize: Early Dumping vs. Late Dumping distinction
• Know: Afferent loop syndrome (Billroth II specific), Alkaline reflux gastritis, Marginal ulcer
• Management of each complication

• The metabolic alkalosis mechanism is a classic exam question
• Know the paradoxically acidic urine explanation
• Treatment sequence: Resuscitate FIRST → then investigate → then surgery

• PPIs vs. H2RAs mechanism differences are key
• H. pylori triple vs. quadruple therapy regimens with exact drugs and duration
• When to use bismuth quadruple therapy (macrolide resistance criteria)

• All three stimuli of parietal cell (ACh, Gastrin, Histamine)
• Three phases (cephalic 30%, gastric 60%, intestinal 10%)
• Cell types in different regions of stomach

• Virchow's/Sister Mary Joseph/Blumer's shelf/Krukenberg signs
• D1 vs. D2 lymphadenectomy controversy
• FLOT chemotherapy + HER2 testing + immunotherapy

Key Facts to Memorize

• H. pylori: 90% DU, 70-90% GU; test of cure with UBT/SAT 4-6 weeks after treatment
• GOO metabolic: Hypokalemic Hypochloremic Metabolic Alkalosis + paradoxically acidic urine
• Diaphragm openings: T8 (IVC), T10 (esophagus), T12 (aorta)
• Caval opening is in the central tendon (doesn't compress IVC)
• Esophageal hiatus is in the right crus (only right vagal fibers keep it closed)

GALL BLADDER & BILIARY TRACT - Detailed Surgical Answers

---

Exam Weightage Guide

---

Q1 (2020) & Q(2018). Physiology of Biliary Secretion, Function of Gallbladder + Physiology of Bile + Significance of LFT in Surgical Patient ⭐⭐⭐⭐⭐

Composition of Bile

---

Bile Salts - Primary and Secondary

• Cholic acid and Chenodeoxycholic acid

• Deoxycholic acid (from cholic acid)
• Lithocholic acid (from chenodeoxycholic acid)

Enterohepatic Circulation of Bile Salts

1. Bile salts secreted into duodenum
2. Aid in fat digestion and absorption (micelle formation) in small intestine
3. 95% actively reabsorbed in the terminal ileum (active sodium-coupled transport)
4. 5% spills into colon → secondary bile acids → partially reabsorbed
5. Return to liver via portal vein → re-secreted into bile
6. Total bile salt pool: 3-5 g, recirculates 2-3 times per meal
7. Interruption (ileal resection, Crohn's ileitis): Bile salt deficiency → fat malabsorption, steatorrhoea, fat-soluble vitamin deficiency

Functions of Bile

1. Fat digestion: Bile salts emulsify fats → form mixed micelles with fatty acids and monoglycerides → facilitate absorption by intestinal enterocytes
2. Fat-soluble vitamin absorption: Vitamins A, D, E, K require bile for absorption
3. Cholesterol excretion: Only route for cholesterol excretion (not metabolized); secreted in bile
4. Bilirubin excretion: Principal route for bilirubin elimination
5. Bicarbonate secretion: Alkalinizes duodenal chyme; protects from peptic digestion
6. Bacteriostatic: Inhibits intestinal bacterial overgrowth
7. Stimulates intestinal motility

Gallbladder Function

1. Concentration: GB concentrates hepatic bile 5-10x by absorbing water and electrolytes (Na+, Cl-, HCO3-) - most important function
2. Storage: Stores 30-50 mL of bile between meals (relaxed state)
3. Secretion: Mucous glands secrete mucus into bile
4. Acidification: GB acidifies bile (H+ secretion) → promotes solubility of calcium salts
5. Absorption of bile acids: Minor amount absorbed in GB
6. Contraction (emptying): Stimulated by CCK (cholecystokinin) - released by fat and protein in duodenum; also by vagal stimulation
7. Relaxation: Inhibited by somatostatin and sympathetic stimulation

---

Significance of Liver Function Tests (LFTs) in Surgical Patient

Aminotransferases (ALT, AST)

• ALT (Alanine aminotransferase): Liver-specific; elevated in hepatocellular damage
• AST (Aspartate aminotransferase): Also in heart, muscle; less liver-specific
• Markedly elevated (>10x): Acute hepatitis, ischemic hepatitis, drug toxicity
• Mildly elevated (1-3x): NAFLD, chronic hepatitis, GERD, right heart failure
• Surgical significance: Very high ALT/AST pre-op → delay elective surgery; risk of acute hepatic failure post-operatively

Alkaline Phosphatase (ALP)

• Found in liver (canalicular membrane), bone, placenta, intestine
• Elevated in cholestatic (biliary) disease (intra- or extrahepatic obstruction)
• Also elevated in: Bone disease (Paget's, metastases), pregnancy
• Isolated ALP elevation → suspect biliary or bone pathology
• Surgical significance: High ALP + high GGT = biliary obstruction → investigate before elective surgery

GGT (Gamma-glutamyltransferase)

• Very sensitive for hepatobiliary disease and alcohol intake
• Elevated in: Cholestasis, alcohol, enzyme-inducing drugs
• Used to confirm hepatic origin of ALP elevation

Bilirubin

• Total bilirubin: Direct (conjugated) + Indirect (unconjugated)
• Elevated direct bilirubin → obstruction or hepatocellular disease
• Surgical significance: Jaundice increases operative risk; elevated bilirubin → renal dysfunction (hepatorenal syndrome), coagulopathy, wound healing impairment, infection risk

Serum Proteins (Albumin, Globulin)

• Albumin: Made exclusively by liver; half-life 20 days; reflects chronic liver synthetic function
• Low albumin (<30 g/L): Poor wound healing, higher infection risk, anastomotic leakage
• Surgical significance: Albumin is one of the strongest predictors of surgical outcome; nutritional optimization required pre-op

Prothrombin Time (PT) / INR

• Reflects synthetic function for clotting factors (II, VII, IX, X - vitamin K dependent)
• Most sensitive indicator of acute liver synthetic failure
• Prolonged PT/INR = impaired liver synthesis → bleeding risk
• Surgical significance: INR >1.5 → significant bleeding risk; requires Vitamin K, FFP, or cryoprecipitate correction before surgery

Liver Surgical Risk Assessment

• Child-Pugh Score (cirrhosis): Bilirubin + Albumin + PT + Ascites + Encephalopathy
  • Class A (5-6): Good risk; Class B (7-9): Moderate; Class C (10-15): Poor - avoid major surgery
• MELD Score (Model for End-stage Liver Disease): Bilirubin + INR + Creatinine
  • Score >15: High operative mortality for elective surgery
  • Score >25: Extremely high risk

---

Q5 & Q14. Bilirubin Metabolism & Pathophysiological Changes in Obstructive Jaundice ⭐⭐⭐⭐⭐

Bilirubin Metabolism - Normal Pathway

• 80% from breakdown of haemoglobin in senescent RBCs (RBC lifespan ~120 days) by reticuloendothelial system (spleen, liver, bone marrow)
• 20% from other haem-containing proteins (myoglobin, cytochrome P450) - "early-labelled bilirubin"
• Haem → Biliverdin (by haem oxygenase) → Unconjugated bilirubin (by biliverdin reductase)
• UCB is insoluble in water, lipid-soluble; transported in blood bound to albumin; cannot be excreted in urine

• UCB dissociates from albumin at the hepatocyte sinusoidal membrane
• Taken up by hepatocytes via organic anion transporters (OATPs)
• Bound intracellularly to ligandin (glutathione S-transferase Y)

• In hepatocyte smooth endoplasmic reticulum
• Catalyzed by UDP-glucuronosyltransferase (UGT1A1)
• UCB + UDP-glucuronic acid → Conjugated (direct) bilirubin (bilirubin diglucuronide = water-soluble)
• Now water-soluble and capable of renal excretion if enters blood

• Active transport across canalicular membrane via MRP2 (multidrug resistance protein 2)
• Excreted into bile canaliculi → bile ducts → CBD → duodenum

• In terminal ileum and colon: Bacterial action → urobilinogen
• Most urobilinogen excreted in feces as stercobilinogen (gives stool brown color) → oxidized to stercobilin
• ~10-20% urobilinogen reabsorbed (enterohepatic circulation) → re-excreted by liver
• ~2-5% urobilinogen enters systemic circulation → excreted in urine as urobilinogen (gives urine yellow color)

---

Types of Jaundice

---

Pathophysiological Changes in Obstructive Jaundice

1. Hepatic Changes

• Intrahepatic cholestasis → bile salt accumulation → hepatocyte injury
• Dilated bile canaliculi and ductules
• Progressive: Biliary cirrhosis (if chronic)
• Kupffer cell dysfunction → reduced bacterial clearance

2. Renal Changes (Very Important Surgically)

• Bile salts are directly nephrotoxic
• Reduced renal blood flow (due to reduced circulating volume, endotoxemia)
• Risk of acute tubular necrosis (ATN) and hepatorenal syndrome
• Endotoxins (from gut, unchecked by Kupffer cells) → renal vasoconstriction
• Prevention: IV mannitol (osmotic diuresis) preoperatively; IV fluids; lactulose to reduce endotoxin absorption; oral bile salts to restore gut barrier

3. Coagulation Abnormalities

• Vitamin K malabsorption (fat-soluble; requires bile for absorption)
• Reduced synthesis of factors II, VII, IX, X
• Prolonged PT/INR → bleeding risk
• Management pre-op: Vitamin K 10 mg IV for 3 days; if inadequate response, check for hepatocellular dysfunction; FFP if urgent surgery

4. Immune Dysfunction / Increased Infection Risk

• Absent bile in intestine → reduced IgA secretion → impaired gut barrier
• Endotoxin absorption from gut lumen → bacteremia, sepsis
• Kupffer cell dysfunction
• Risk of: Cholangitis, wound infection, hepatic abscess

5. Cardiovascular Changes

• Bradycardia (bile salts depress cardiac conduction)
• Hypotension (reduced vasomotor tone)
• Increased risk of intraoperative cardiac arrest

6. Wound Healing Impairment

• Low albumin (synthetic dysfunction) → poor collagen synthesis
• Vitamin deficiencies (A, D, E, K)

7. Malnutrition

• Fat malabsorption → steatorrhoea
• Fat-soluble vitamin deficiency (A, D, E, K)
• Weight loss, muscle wasting

8. Pruritis

• Bile salt deposition in skin → intense itching
• Management: Cholestyramine, rifampicin

Summary: Pre-operative Optimization for Obstructive Jaundice

1. Correct coagulopathy: Vitamin K (IV), FFP if urgent
2. Renal protection: IV fluids, mannitol pre-op, lactulose
3. Nutritional optimization: Parenteral/enteral nutrition
4. Treat cholangitis first (IV antibiotics)
5. Biliary drainage before major surgery if bilirubin >200 µmol/L (PTBD or ERCP stenting)
6. Prophylactic antibiotics at induction

---

Q4 & Q13 & Q15. Surgical Anatomy of GB, CBD + Biliary Tract ⭐⭐⭐⭐⭐

Gallbladder Anatomy

• Fundus: Most distal, projects beyond liver edge; touchable at right costal margin at MCL (Murphy's point); covered by peritoneum
• Hartmann's pouch: Outpouching at the neck - gallstones frequently lodge here; can compress the CBD (Mirizzi syndrome)
• Cystic duct: Length 2-4 cm; connects neck to CBD; lined by spiral mucosal folds (valves of Heister)

• Superior: Liver (quadrate lobe)
• Inferior: First part duodenum, hepatic flexure of colon
• Anterior: Anterior abdominal wall (fundus)

• Cystic artery: Usually a branch of the right hepatic artery; courses through the Triangle of Calot (cystohepatic triangle)
• Variations: Cystic artery may arise from left hepatic, common hepatic, gastroduodenal, or directly from celiac axis - extremely important to identify correctly during cholecystectomy

---

Triangle of Calot (Cystohepatic Triangle) - MOST IMPORTANT LANDMARK

• Medial: Common hepatic duct
• Lateral/Superior: Cystic duct (lower boundary)
• Superior: Inferior surface of liver (right lobe)

• Cystic artery (identified and divided here)
• Cystic lymph node (Lund's node)
• Occasionally: Aberrant right hepatic artery

---

Common Bile Duct (CBD) - Anatomy

1. Supraduodenal: From junction of cystic duct + common hepatic duct (CHD) → upper border of duodenum; runs in free edge of lesser omentum (hepatoduodenal ligament)
2. Retroduodenal: Behind first part of duodenum
3. Pancreatic: Runs through or behind the head of pancreas (groove)
4. Intraduodenal (intramural): Passes obliquely through wall of 2nd part of duodenum; unites with main pancreatic duct (Wirsung) at the ampulla of Vater; controlled by sphincter of Oddi

• Anterior: CBD (right) + hepatic artery proper (left) - "the two pillars of the portal triad"
• Posterior: Portal vein (most posterior)
• CBD: Right side; Hepatic artery: Left side; Portal vein: Posterior

• Smooth muscle sphincter surrounding distal CBD + PD at ampulla
• Maintains basal tone preventing bile/pancreatic juice reflux
• Relaxes during GB contraction (CCK-mediated) to allow bile flow
• Basal pressure ~13 mmHg; prevents duodenobiliary reflux

---

Extrahepatic Biliary Ducts (Full Anatomy)

• Right hepatic duct + left hepatic duct → Common hepatic duct (CHD) (joins at hepatic hilum)
• CHD + cystic duct → Common bile duct (CBD)
• CHD length ~4 cm; CBD length ~8-10 cm
• Entire extrahepatic biliary tree from hilum to duodenum = ~12-15 cm

---

Q4 (cont.). Management of Acute Cholecystitis ⭐⭐⭐⭐⭐

Pathophysiology

• Obstruction of cystic duct by stone → GB distension → mucosal ischemia → chemical/bacterial inflammation
• 90% of cases associated with gallstones (acute calculous cholecystitis)
• 10%: Acute acalculous cholecystitis - critically ill patients (ICU, post-major surgery, trauma, burns) - worse prognosis

Clinical Features

• Severe RUQ/epigastric pain (constant, not colicky - distinguishes from biliary colic)
• Pain radiating to right shoulder/interscapular area
• Fever (38-38.5°C), nausea, vomiting
• Murphy's sign: Arrest of inspiration when palpating RUQ (pressure on inflamed GB causes pain) - 95% specific when positive
• Tenderness + guarding in RUQ
• Palpable mass (GB empyema or pericolecystic collection) in 30%

• Fever + RUQ pain + Jaundice

• Charcot's triad + Hypotension + Confusion/Altered mental status

Investigations

1. Ultrasound abdomen - investigation of choice: Calculi, thickened GB wall (>4 mm), pericholecystic fluid, positive sonographic Murphy's sign, CBD dilatation
2. Blood tests: FBC (leukocytosis), LFTs (mildly raised ALP, bilirubin), CRP (elevated)
3. CT abdomen: Complications - perforation, gangrenous cholecystitis, pericholecystic abscess, emphysematous cholecystitis
4. HIDA scan (cholescintigraphy): If US equivocal; non-filling of GB = cystic duct obstruction - most sensitive
5. MRCP: If CBD stones suspected (dilated CBD, jaundice)
6. Blood cultures: If fever, sepsis

Tokyo Guidelines (TG18) - Severity Grading

• Grade I (Mild): No organ dysfunction, no severe local inflammation
• Grade II (Moderate): WBC >18,000, palpable tender mass, >72 hrs symptoms, marked local inflammation
• Grade III (Severe): Organ dysfunction (cardiovascular, neurological, respiratory, renal, hepatic, haematological)

Management

Initial (All Grades):

• IV fluids, nil-by-mouth
• IV analgesia (diclofenac IM/IV reduces GB pressure and spasm; opioids)
• IV antibiotics: Gram-negative coverage + anaerobes (e.g., piperacillin-tazobactam, cefuroxime + metronidazole)
• Proton pump inhibitor
• Monitor: Urine output, temperature, blood tests

Definitive Treatment:

• Tokyo Guidelines TG18 recommendation: Early lap cholecystectomy for Grade I and II
• Lower conversion rate, shorter hospital stay, cost-effective compared to delayed surgery
• Timing: Within 72 hours of symptom onset (before inflammatory mass forms)

• For Grade III (severe) or high-risk surgical patients
• Ultrasound/CT-guided drainage of GB under local anaesthesia
• Provides temporary relief; interval cholecystectomy after recovery

• After initial conservative management if surgery not done early
• Traditional approach (increasingly replaced by early surgery)

---

Q2. Anomalies of Gallbladder and CBD (20 marks) ⭐⭐⭐

Anomalies of the Gallbladder

• Agenesis: Absent GB (rare, ~1 in 7,500); associated with other anomalies
• Duplication: Double GB - each with its own cystic duct; incidentally found; need both removed if symptomatic
• Triple GB: Extremely rare

• Left-sided GB (situs inversus or isolated): Associated with biliary anomalies; higher CBD injury risk
• Intrahepatic GB: Completely buried within liver parenchyma; higher risk during cholecystectomy
• Floating/Pedunculated GB: Long mesentery; prone to torsion; presents as acute abdomen

• Phrygian cap deformity: Fundus folded back on itself (like Phrygian cap); usually incidental; no clinical significance
• Hartmann's pouch: Normal variant (prominent outpouching at neck); clinically significant - stones lodge here

• Porcelain gallbladder: Calcification of GB wall; previously thought high cancer risk - now reassessed (risk lower than historical reports); most treated conservatively unless symptomatic
• Adenomyomatosis: Hyperplastic change of GB wall; Rokitansky-Aschoff sinuses

Anomalies of the Bile Ducts (Critical for Surgery!)

1. Short cystic duct: High risk of clipping common hepatic duct
2. Long cystic duct: Runs parallel to CBD for a long distance before joining
3. Low insertion of cystic duct: Joins CBD very close to the ampulla
4. Medial insertion: Cystic duct crosses posteriorly to join on left side of CBD - risk of misidentification
5. Absence of cystic duct: Direct insertion of GB into CBD

• Accessory hepatic duct: Extra duct draining segment of liver directly into GB/CBD/cystic duct
• Aberrant right hepatic duct: Drains into CHD, CBD or cystic duct at a low level; if damaged during cholecystectomy → bile leak
• Low confluence: Right and left hepatic ducts join low (close to GB bed) - risk of injury

• Caterpillar hump artery (Moynihan's hump): Right hepatic artery loops into triangle of Calot - can be confused with cystic artery
• Double cystic artery
• Cystic artery arising from left hepatic, GDA, or celiac
• Anterior position of right hepatic artery - at risk during cholecystectomy

---

Q3. Interventional Radiology of GB - ERCP and MRCP ⭐⭐⭐

ERCP (Endoscopic Retrograde Cholangiopancreatography)

• CBD stones (choledocholithiasis) - therapeutic
• Cholangitis requiring bile drainage
• Bile duct stricture (diagnostic + stenting)
• Biliary leak (post-cholecystectomy) - stenting
• Choledochal cyst evaluation
• Ampullary tumors (diagnostic)
• Pre-operative decompression in malignant obstructive jaundice
• Sphincter of Oddi manometry

1. Patient sedated; side-viewing duodenoscope (TJF-type) used
2. Papilla of Vater identified in 2nd part of duodenum
3. Cannula introduced into papilla; contrast injected under fluoroscopy
4. Biliary and/or pancreatic ducts outlined
5. Therapeutic interventions performed:
   • Endoscopic sphincterotomy (EST): Cutting the sphincter of Oddi with an electrosurgical wire (sphincterotome) → opens the distal CBD → stones pass or removed with Dormia basket/balloon
   • Stone extraction: Dormia basket or balloon catheter
   • Stent insertion: Plastic or metal stent for strictures, malignant obstruction
   • Nasobiliary drain: For cholangitis/bile leak

• Pancreatitis (most common, 3-5%): Usually mild and self-limiting
• Bleeding (post-sphincterotomy)
• Cholangitis
• Perforation (retroduodenal or duodenal)
• Contrast reactions
• Overall morbidity 5-10%; mortality ~0.1-0.2%

---

MRCP (Magnetic Resonance Cholangiopancreatography)

• Suspected CBD stones before laparoscopic cholecystectomy
• Evaluation of biliary strictures
• Choledochal cyst characterization
• Bile duct injury assessment
• Primary sclerosing cholangitis (PSC)
• Pancreatic duct pathology (chronic pancreatitis, IPMN)
• Pre-operative biliary anatomy mapping

• Non-invasive; no radiation; no risk of pancreatitis
• No contrast needed (uses T2 signal from bile)
• 3D reconstruction; full anatomical mapping
• Views hepatic ducts above strictures (ERCP cannot pass stricture)

• Purely diagnostic - no therapeutic capability
• Lower spatial resolution than direct cholangiography
• Cannot visualize small stones <3 mm

• If therapeutic intervention is planned: ERCP first (diagnostic + therapeutic in one)
• If diagnosis needed without intervention: MRCP (safer)
• Modern protocol: MRCP to diagnose CBD stones → ERCP if confirmed (for stone extraction)

---

Q6 (2014). Endoscopy vs. Laparoscopy for CBD Stone (Transcystic + Transcholedochal + ERCP) ⭐⭐⭐⭐

Background

Option 1: Preoperative ERCP + Endoscopic Sphincterotomy + Stone Extraction → Laparoscopic Cholecystectomy

1. ERCP performed (see Q3)
2. Sphincterotomy: Electrosurgical incision of sphincter of Oddi
3. Stone extracted with Dormia basket (wire basket) or balloon catheter
4. Cholangiogram to confirm clearance
5. Laparoscopic cholecystectomy planned separately (same admission or interval)

---

Option 2: Laparoscopic Common Bile Duct Exploration (LCBDE) - Single-Stage Approach

A. Transcystic Route (Preferred if feasible)

1. Intraoperative cholangiogram (IOC) performed first to confirm CBD stones
2. Guidewire passed through cystic duct into CBD
3. Cystic duct dilated with balloon dilator (serial dilators or balloon up to 8 mm)
4. 4 mm flexible choledochoscope introduced through cystic duct into CBD
5. Stones visualized under direct vision
6. Stone fragmented if needed (laser lithotripsy / electrohydraulic lithotripsy)
7. Stones extracted with Dormia basket under choledochoscopic view
8. Completion cholangiogram to confirm clearance
9. Cystic duct ligated and divided; cholecystectomy completed
10. No T-tube needed (cystic duct closure)

B. Transcholedochal Route (Choledochotomy)

1. CBD identified in hepatoduodenal ligament
2. Stay sutures placed on anterior CBD wall
3. Longitudinal choledochotomy 10-15 mm in supraduodenal CBD
4. Stones milked out manually or extracted with Dormia basket/forceps
5. Flexible choledochoscope inserted to confirm clearance and visualize intrahepatic ducts
6. Residual stones: Balloon sweep, lithotripsy
7. T-tube drainage (Kehr's tube) inserted through choledochotomy:
   • Short arm in CBD (pointing up and down); long arm exits abdomen
   • Functions: Decompresses CBD; maintains lumen; route for post-op cholangiogram; extraction of residual stones
8. T-tube cholangiogram at 7-10 days post-op to confirm clearance
9. T-tube removed at 10-14 days if cholangiogram clear

• Increasingly used; CBD closed directly over choledochoscopy port
• Requires bile duct ≥8 mm, no distal obstruction, complete stone clearance, good tissue quality

• Bile leak
• Stricture at choledochotomy site (long-term)
• CBD injury
• T-tube dislodgement/biloma

---

Comparison Table: ERCP vs. Laparoscopic CBD Exploration

---

Q9 (2014) & Q (2014). Technique of Open and Laparoscopic Cholecystectomy + Different Methods of Cholecystectomy ⭐⭐⭐⭐⭐

Methods of Cholecystectomy

1. Open cholecystectomy (conventional)
2. Laparoscopic cholecystectomy (gold standard)
3. Single-incision laparoscopic cholecystectomy (SILS)
4. Robotic-assisted cholecystectomy
5. Natural orifice transluminal endoscopic surgery (NOTES) - experimental
6. Mini-laparotomy cholecystectomy (mini-chol) - 5-7 cm incision; developing world

---

A. Laparoscopic Cholecystectomy (Gold Standard) ⭐⭐⭐⭐⭐

1. 10 mm umbilical port (Hasson or Veress technique): Camera port
2. 10-12 mm epigastric port (4 cm below xiphoid, right of midline): Main working port; clip applicator
3. 5 mm right subcostal port (MCL): Retraction port
4. 5 mm right flank port: Retraction of GB fundus

• Veress needle at umbilicus (or open Hasson technique for prior surgery/suspected adhesions)
• Insufflate with CO2 to 12-14 mmHg
• 10 mm trocar inserted; 30° angled scope introduced

• Patient tilted: Head-up + left lateral → liver falls up and away; GB exposed
• Fundus grasped and retracted superiorly (cephalad) by fundal grasper
• Hartmann's pouch grasped and retracted laterally (to open triangle of Calot)

• Peritoneum on anterior and posterior aspects of triangle of Calot incised
• Fundus-first retraction (antegrade/lateral retraction): Hartmann's pouch pulled laterally → opens the triangle
• Dissection with hook diathermy/scissors + suction/irrigation
• Fat and areolar tissue cleared until Critical View of Safety (CVS) achieved:
  • Lower third of GB dissected free from GB bed (liver)
  • Only 2 structures seen entering GB: Cystic artery + cystic duct
  • Both structures clearly separated from CBD

• Once CVS achieved: 2 clips proximally + 1 clip distally on cystic artery → divide between
• 2 clips proximally + 1-2 clips distally on cystic duct → divide between
• Intraoperative cholangiogram may be performed through cystic duct before clipping (selective or routine)

• GB dissected from liver bed with hook diathermy working from cystic duct/artery clipped ends toward fundus
• Hemostasis of GB bed

• GB placed in retrieval bag (Endobag)
• Extracted through 10 mm umbilical port (or epigastric if GB large/stones)
• Spillage avoided; if spilled, stones washed and retrieved (dropped stones → abscess years later)
• Abdominal cavity irrigated; hemostasis checked

• 10/12 mm port sites closed with fascial closure (Endoclose or J-needle)
• Skin closed with subcuticular sutures
• Operative time: 45-75 minutes

---

B. Open Cholecystectomy

• Kocher's (right subcostal) incision: Extends from midline 2-3 cm below xiphoid obliquely to right, parallel to costal margin; excellent GB exposure; standard for open cholecystectomy
• Right paramedian incision: Older approach
• Midline laparotomy: When uncertainty or emergency

1. Kocher incision; liver retracted superiorly with retractor
2. Fundus grasped; GB exposed
3. Triangle of Calot dissected; cystic duct and artery identified
4. Retrograde (fundus-down) or antegrade (fundus-first) dissection
5. Cystic artery ligated and divided; cystic duct ligated with 2/0 Vicryl and divided
6. Intraoperative cholangiogram via cystic duct (if routine policy)
7. GB removed from liver bed with diathermy
8. Drain placed in subhepatic space (optional)
9. Closure in layers (mass closure vs. layered)

• Unclear anatomy (cannot achieve CVS)
• Severe adhesions/fibrosis
• Suspected GB cancer
• Uncontrolled bleeding
• CBD injury
• Bile duct anomaly requiring open reconstruction
• Perforation of abdominal organ

---

Q10 (2015/2018). CF, Ix & Management of Choledochal Cyst ⭐⭐⭐⭐

Definition

Etiology

• Anomalous Pancreaticobiliary Ductal Junction (APBDJ): Long common channel where the pancreatic duct joins the CBD outside the duodenal wall (>10 mm long channel outside sphincter of Oddi) → allows reflux of pancreatic secretions into biliary tree → protein plugs obstruct junction → distal obstruction → cystic dilatation
• Weakness of the biliary wall at the junction
• More common in Asian populations and females (3:1 female:male)

Todani Classification (5 Types)

Clinical Features

1. RUQ pain
2. Jaundice
3. Palpable RUQ mass

• Cholangitis (recurrent)
• Gallstones (within cyst)
• Pancreatitis
• Biliary cirrhosis (chronic)
• Cholangiocarcinoma (most feared): Risk up to 15-20% lifetime (higher with intrahepatic involvement - up to 75% in some Japanese series); risk persists even after drainage procedures (hence complete excision required)
• Portal hypertension (if biliary cirrhosis)

Investigations

1. Ultrasound: First-line; shows cystic biliary dilatation, relationship to pancreas
2. MRCP: Investigation of choice; non-invasive; defines anatomy of APBDJ; type classification; extent
3. CT abdomen: Staging; local invasion; vascular anatomy
4. ERCP: Shows APBDJ; therapeutic in Type III (sphincterotomy)
5. HIDA scan: Biliary function, bile leakage post-op

Operative Management

Type I: Complete excision + Roux-en-Y hepaticojejunostomy

1. Cholecystectomy first
2. Kocher maneuver to expose distal CBD and cyst
3. Identify distal extent of cyst at junction with pancreatic duct (intraoperative US helpful)
4. Transect CBD distally (as close to pancreatic duct as possible without entering pancreas)
5. Mobilize cyst superiorly to level of common hepatic duct bifurcation
6. Transect at confluence (or higher if abnormal mucosa)
7. Roux-en-Y hepaticojejunostomy (or hepaticoduodenostomy in children):
   • Roux limb 40-60 cm; anastomosis between hepatic duct remnant and jejunum
   • End-to-side anastomosis; single layer absorbable sutures

Type II: Diverticulectomy and closure of biliary wall

Type III (Choledochocele): Endoscopic sphincterotomy (usually sufficient); rarely surgical excision

Type IVa: Extrahepatic component excised + Roux-en-Y HJ; intrahepatic component monitored; hepatic resection if localized

Type V (Caroli's Disease):

• Segmental disease: Hepatic resection (lobectomy)
• Diffuse disease: Liver transplantation (only cure)

---

Q11 (2016). Etiology, CF & Ix of CBD Stones + ERCP + Laparoscopic Exploration ⭐⭐⭐⭐⭐

Etiology of CBD Stones

• Brown pigment stones: Infection with E. coli → β-glucuronidase deconjugates bilirubin; associated with biliary stasis, stricture, Caroli's disease, choledochal cyst
• More common in Asian populations (recurrent pyogenic cholangitis)

• Most common in Western countries
• Cholesterol or black pigment stones originally from GB → pass through cystic duct into CBD

• Gallstones in GB (most important risk factor)
• Biliary stricture
• Choledochal cyst
• Caroli's disease
• Post-cholecystectomy (retained stones)
• Parasitic infestation (Clonorchis sinensis, Ascaris - cause pigment stones)
• Haemolysis (black pigment stones)

Clinical Features

• Often asymptomatic (incidentally found on USS)
• Biliary colic: Intermittent RUQ or epigastric pain radiating to back/right shoulder
• Obstructive jaundice: Deep jaundice, pale stools, dark urine, pruritus (if complete obstruction)
• Cholangitis (Charcot's triad): Fever + jaundice + RUQ pain
• Pancreatitis: Stone impacted at ampulla → acute pancreatitis

Investigations

1. LFTs: Raised ALP, GGT, bilirubin (conjugated); AST/ALT mildly elevated
2. Ultrasound: CBD dilatation (>8 mm); stones seen in ~50% (gas-filled duodenum obscures distal CBD)
3. MRCP: Best non-invasive; 95% sensitivity for CBD stones; defines size, number, location
4. EUS (Endoscopic Ultrasound): 95-98% sensitivity; useful for small stones missed on MRCP; CBD scanned from duodenum
5. ERCP: Diagnostic + therapeutic; reserved when therapeutic intent
6. Intraoperative Cholangiogram (IOC): During cholecystectomy - definitive; shows CBD, filling defects

Management

---

Q12 & Q15. Classification & Management of Iatrogenic Bile Duct Injury (BDI) ⭐⭐⭐⭐⭐

Incidence

• Open cholecystectomy: 0.1-0.2%
• Laparoscopic cholecystectomy: 0.3-0.7% (higher than open - loss of tactile feedback, perspective errors)

Mechanisms of BDI During Laparoscopic Cholecystectomy

1. Misidentification error: CBD mistaken for cystic duct (especially when cystic duct is short and CBD is mistakenly clipped as cystic duct)
2. Tenting/traction: Excessive lateral traction on Hartmann's pouch tents up the CBD into the operative field → "tenting injury" - CBD lifted and clipped
3. Thermal injury: Diathermy heat spread to CBD
4. Clip misplacement: Clip placed across CBD
5. Failure to achieve Critical View of Safety
6. Excessive dissection deep to triangle of Calot
7. Bleeding → hasty clipping/diathermy → CBD injury

• Achieve Critical View of Safety (CVS) BEFORE clipping
• Routine intraoperative cholangiogram (IOC) - identifies bile ducts before division
• Fundus-first (top-down) approach for difficult cases
• Low threshold for conversion to open
• Experienced assistance
• Use of fluorescence imaging (ICG cholangiography - near-infrared)

---

Classification Systems

Strasberg Classification (Most Widely Used)

Bismuth-Strasberg Classification (Strictures)

Management of BDI

A. Intraoperative Recognition (Best Scenario)

• Clip application or suture
• Subhepatic drain

• Primary repair over T-tube (if injury <50% circumference and healthy tissue)
• T-tube left for 6 weeks; T-tube cholangiogram before removal

• If low (E1-E2) and <1 cm loss:
  • End-to-end repair over T-tube (if no tension, healthy ends) - poor long-term results; stricture rate high
  • PREFERRED: Roux-en-Y hepaticojejunostomy - much better long-term patency
• If high (E3-E5) or significant tissue loss:
  • Roux-en-Y hepaticojejunostomy at the appropriate level
  • May need bilateral (right + left duct) anastomoses for E4/E5
• If inadequate expertise: Place drains, close → refer to HPB center

B. Delayed Recognition (Postoperative)

1. Resuscitate; CT for collections
2. Drain collections percutaneously
3. ERCP + sphincterotomy + stent → reduces CBD pressure → promotes cystic duct/minor leak closure
4. HIDA scan to confirm leak sealed
5. Surgery only if ERCP fails or major injury

1. MRCP / PTC to define level and extent
2. Percutaneous transhepatic cholangiography + drainage (PTCD): Decompresses biliary tree; treats cholangitis; defines anatomy
3. Definitive repair: Roux-en-Y hepaticojejunostomy at the HPB center (best outcomes)
4. Endoscopic balloon dilatation + stenting: For low Bismuth I-II strictures; needs repeated procedures
5. Outcome: 85-90% long-term success with surgical repair at specialist centers

---

Q (2021). Mirizzi Syndrome ⭐⭐⭐⭐ (10 marks)

Definition

Pathophysiology

1. Large stone impacted in Hartmann's pouch or cystic duct
2. Stone compresses the adjacent CHD → partial or complete biliary obstruction
3. With time, pressure necrosis → erosion through GB wall and CHD wall → cholecystocholedochal fistula

McSherry Classification

Clinical Features

• Obstructive jaundice (can be partial or complete)
• Recurrent cholangitis, fever
• RUQ pain
• History of cholelithiasis
• Mimics cholangiocarcinoma clinically and radiologically

Investigations

• MRCP: Best for preoperative diagnosis; shows characteristic appearance of extrinsic compression at level of CHD with intraluminal stones; sparing of the CBD below
• ERCP: Diagnostic + therapeutic (stenting); shows level of obstruction
• EUS: Helpful
• CT: May show but MRCP is superior
• Preoperative diagnosis rate: Only 8-62% (often diagnosed intraoperatively)

Management

• Laparoscopic or open cholecystectomy (depends on expertise and inflammation)
• Partial cholecystectomy leaving posterior GB wall on CHD (safer)
• Often requires open surgery due to severe inflammation

• Partial cholecystectomy
• Stone removed from CHD
• Small defect: Primary closure over T-tube
• Large defect: Roux-en-Y hepaticojejunostomy

• Open surgery mandatory
• Complete removal of GB + bile duct reconstruction
• Roux-en-Y hepaticojejunostomy (standard for Types III-IV)

• Repair cholecystoenteric fistula + biliary reconstruction

---

Q (2016/2025). Biliary Fistula (10 marks) ⭐⭐⭐

Definition

Classification

1. Cholecystoduodenal fistula (most common internal - 60-75%): Between GB and duodenum; complication of chronic cholecystitis and gallstones; may cause gallstone ileus (stone >2.5 cm passes through fistula → obstructs ileocaecal valve)
2. Cholecystocolic fistula: Between GB and colon; causes chronic diarrhea, fat malabsorption, loss of bile salts
3. Choledochoduodenal fistula: CHD/CBD to duodenum; chronic cholangitis
4. Cholecystogastric fistula: Rare

1. Post-operative: After cholecystectomy (cystic duct stump leak, CBD injury, dropped stone) - most common cause of external biliary fistula today
2. Post-traumatic: Liver trauma
3. Spontaneous (rare): Chronic empyema of GB eroding through abdominal wall; or after hepatic abscess drainage

Investigations

• ERCP / MRCP: Define anatomy of fistula
• HIDA scan: Confirms bile leak, shows fistula tract
• Fistulogram: Inject contrast into external fistula
• Bloods: LFTs, bilirubin; amylase if associated with pancreatitis
• CT abdomen: Collections, pneumobilia (air in biliary tree), fistula tract

Management

1. Resuscitate + drain collections (percutaneous)
2. ERCP + sphincterotomy + stent → reduces biliary pressure → minor leaks close
3. Most Type A (minor) leaks close with ERCP stenting alone
4. Surgery (Roux-en-Y HJ) only for major injuries or failure of ERCP

1. Elective surgery (if symptomatic): Close fistula + cholecystectomy
2. Gallstone ileus: Emergency laparotomy; enterotomy + stone removal; cholecystectomy + fistula closure at same or separate sitting

---

Q (2014). Biliary Enteric Anastomosis (10 marks) ⭐⭐⭐

Indications

1. CBD stricture (benign: post-cholecystectomy injury, chronic pancreatitis; malignant: cholangiocarcinoma, pancreatic Ca)
2. Choledochal cyst excision
3. Chronic choledocholithiasis (elderly, recurrent)
4. Post-BDI reconstruction
5. Palliative bypass for unresectable pancreatic/biliary cancer

Types

1. Choledochoduodenostomy (CDD)

• Side-to-side anastomosis between CBD and 1st part of duodenum
• Advantages: Simple, no bowel division, good blood supply
• Disadvantages: "Sump syndrome" - food and debris collect in blind distal CBD segment between duodenum and sphincter → infection/stone formation; reflux gastritis
• Use: Elderly patients with benign obstruction; low-risk reconstruction

2. Choledochojejunostomy

• CBD to defunctionalized Roux loop of jejunum
• Less reflux than CDD
• Rarely used as isolated procedure

3. Roux-en-Y Hepaticojejunostomy (HJ) - GOLD STANDARD ⭐

• Most widely used biliary reconstruction
• End-to-side anastomosis between common hepatic duct/right+left hepatic ducts and Roux limb of jejunum (40-60 cm Roux limb to prevent reflux)
• Advantages: Low reflux; excellent long-term patency; adaptable to any level; can be right + left duct if needed
• Disadvantages: Complex; requires two anastomoses (bilioenteric + jejunojejunostomy)
• Technique:
  1. Identify CHD stump or hepatic duct at appropriate level
  2. Jejunum divided 40 cm from ligament of Treitz
  3. Roux limb brought up retrocolic (through mesocolon) or antecolic
  4. End-to-side anastomosis: Posterior wall first with 3/0 or 4/0 PDS (absorbable); then anterior wall
  5. Single layer anastomosis preferred; interrupted sutures at the posterior wall
  6. Jejunojejunostomy (Roux-en-Y anastomosis) 40-60 cm distally

4. Hepaticoduodenostomy

• Hepatic duct to duodenum
• Used in children after choledochal cyst excision
• Risk of reflux over time → rarely used in adults

5. Intrahepatic Bilioenteric Anastomosis (Hutson-Blumgart)

• For high Bismuth IV/V injuries
• Left hepatic duct exposed via segment III approach (lowering the hilar plate)
• Anastomosis to Roux loop
• For cases where hilar approach impossible

---

Q (2014). Mx of Intrahepatic Bile Duct Stones (15 marks) ⭐⭐⭐

Definition

Etiology

• Recurrent pyogenic cholangitis (RPC): Bacterial infection (E. coli, Klebsiella) → β-glucuronidase → calcium bilirubinate stones + mud
• Caroli's disease (congenital)
• Primary sclerosing cholangitis (PSC)
• Biliary strictures
• Liver fluke infestation (Clonorchis sinensis)

Clinical Features

• Recurrent episodes of: Right upper quadrant pain + fever (cholangitis) + jaundice
• Eventually: Hepatic abscess, secondary biliary cirrhosis, portal hypertension
• Risk of cholangiocarcinoma (especially in PSC and Caroli's)

Investigations

• LFTs, blood cultures (during acute attacks)
• Ultrasound + MRCP (best non-invasive; shows extent, strictures)
• CT: Hepatic atrophy, stones, strictures
• ERCP/PTC: Decompression during acute cholangitis + define anatomy

Management

• IV antibiotics + biliary decompression (ERCP/PTCD)
• Percutaneous hepatic drainage for hepatic abscess

• Percutaneous access to intrahepatic ducts
• Flexible cholangioscope introduced; stones fragmented with lithotripsy (laser/EHL)
• Stone clearance under direct vision

• Left lateral or left hepatic resection (stones most common in left lobe in Asian patients due to anatomy)
• Removes stone-containing segment + irreversibly damaged/atrophic parenchyma
• Combination with biliary reconstruction (HJ) if stricture at confluence

• For end-stage PSC with cirrhosis or Caroli's disease with diffuse involvement

---

Summary: Priority Study Order for Exam

THE BIG 5 (Must master):

1. Bile duct injury - classification (Strasberg/Bismuth), mechanism, prevention, management
2. Laparoscopic cholecystectomy - full technique with Critical View of Safety
3. CBD stones - ERCP vs. transcystic vs. transcholedochal
4. Obstructive jaundice - bilirubin metabolism + all pathophysiological changes
5. LFTs in surgical patient - each test, what it means, surgical significance

High-Yield Facts to Memorize:

• CVS (Critical View of Safety): Only 2 structures entering GB before clipping
• Strasberg Type A = most common post-lap-chol bile leak (cystic duct stump) → ERCP + stent
• Bismuth I-V stricture levels (E1-E5 in Strasberg)
• Gold standard biliary reconstruction = Roux-en-Y hepaticojejunostomy with 40-60 cm Roux limb
• Choledochal cyst: Complete excision mandatory (not drainage) due to cholangiocarcinoma risk
• Mirizzi: External compression of CHD by stone in cystic duct/Hartmann's pouch
• Charcot's triad: CBD stone + cholangitis; Reynolds pentad: + hypotension + confusion = septic cholangitis
• T-tube functions: Decompression + lumen maintenance + route for post-op cholangiogram + stone extraction

References:

• Bailey and Love's Short Practice of Surgery, 28th Edition
• Sabiston Textbook of Surgery
• Current Surgical Therapy, 14th Edition
• Blumgart's Surgery of the Liver, Biliary Tract and Pancreas
• Schwartz's Principles of Surgery

---

Priority Study Guide for SMALL INTESTINE

THE BIG 6 (Must Master - Appear Every Year):

• Memorize: SNAP protocol + FRIENDS mnemonic
• Role of TPN: Bowel rest + nutrition + reduce output
• Key point: Sepsis control is the #1 priority before anything else

• Key differentials from Crohn's: Caseating granulomas, patulous ICV, transverse ulcers, positive Mantoux/IGRA, AFB+
• CT feature: Necrotic mesenteric LN with central caseation
• ATT: 2 months HRZE + 4-7 months HR

• Truelove & Witts severity (>6 bloody stools + fever/tachycardia/low Hb/raised ESR = severe)
• Surgical gold standard: Restorative proctocolectomy + IPAA (J-pouch)
• Emergency: Subtotal colectomy + end ileostomy first

• "Pain out of proportion to examination" = classic AMI
• SMA embolism (50%) + SMA thrombosis (25%) + NOMI (20%) + MVT (5%)
• CT angiography = investigation of choice; Second-look laparotomy = essential

• Critical lengths: <100 cm (no colon) or <60 cm (with colon) = permanent TPN
• Treatment: Teduglutide (GLP-2 analogue) - reduces TPN requirements
• Surgical: STEP procedure (Serial Transverse Enteroplasty)

• Double bubble = duodenal atresia (Down syndrome); apple-peel = Type IIIb jejunal atresia
• Malrotation with volvulus = Surgical emergency; Ladd's procedure
• Hirschsprung's: Diagnosis by suction rectal biopsy; absent ganglion cells; RAIR absent

High-Yield Quick Facts:

• Carcinoid: 24-hr urine 5-HIAA + Ga-68 DOTATATE PET-CT; Lutetium-177 PRRT for metastatic
• Crohn's: Skip lesions, transmural, non-caseating granulomas, perianal disease; strictureplasty (Heineke-Mikulicz)
• HOI: Restrict hypotonic fluids; ORS (Na 90 mmol/L); loperamide; octreotide
• Typhoid perforation: Small oval perforations on antimesenteric border of terminal ileum; resection + end ileostomy safest